# Estrogen Supplementation and Bone Health in Women With CF

> **NCT05704036** · PHASE4 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 75 (estimated)

## Conditions studied

- Cystic Fibrosis
- Hypoestrogenism

## Interventions

- **DRUG:** Transdermal estrogen
- **DRUG:** Progesterone

## Key facts

- **NCT ID:** NCT05704036
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-02
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2025-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05704036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05704036, "Estrogen Supplementation and Bone Health in Women With CF". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05704036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*